Meng Ying, Thornburg Loralei L, Dreisbach Caitlin, Orzolek Charlotte, Kautz Amber, Murphy Hannah R, Rivera-Núñez Zorimar, Wang Christina, Miller Richard K, O'Connor Thomas G, Barrett Emily S
School of Nursing, University of Rochester, Rochester, NY, USA.
Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY, USA.
Int J Obes (Lond). 2025 May;49(5):954-964. doi: 10.1038/s41366-025-01743-3. Epub 2025 Mar 17.
Intrauterine factors can impact fetal and child growth and may underlie the developmental origins of childhood obesity. Sex steroid hormone exposure during pregnancy is a plausible target because of the impact on placental vascularization, nutrient transportation, adipogenesis, and epigenetic modifications. In this study we assessed maternal sex steroid hormones in each trimester in relation to birthweight, neonatal adiposity, and infant growth trajectories, and evaluated sensitive windows of development.
Participants from a prospective pregnancy cohort who delivered at term were included in the analysis (n = 252). Estrone, estradiol, and estriol, as well as total and free testosterone throughout gestation were assessed using high-performance liquid chromatography and tandem mass spectrometry. Path analyses were used to assess the direct associations of sex steroid hormones in each trimester with birth outcomes and infant growth trajectories (birth to 12 months) adjusting for covariates and considering moderation by sex.
The associations between prenatal sex steroid hormones and fetal/infant growth varied by sex and timing of hormone exposure. First-trimester estrone was associated with higher birthweight z-scores (β = 0.37, 95% CI: 0.02, 0.73) and truncal skinfold thickness (TST) at birth (β = 0.94, 95% CI: 0.34, 1.54) in female infants. Third-trimester total testosterone was associated with higher TST at birth (β = 0.47, 95% CI: 0.03, 0.86) in both sexes. First-trimester estrone and estradiol and first- and third-trimester testosterone were associated with lower probabilities of high stable weight trajectory compared to low stable weight trajectory (Estrone: β = -3.87, 95% CI: -6.59, -1.16; Estradiol: β = -4.36, 95% CI: -7.62, -1.11; First-trimester testosterone: β = -3.53, 95% CI: -6.63, -0.43; Third-trimester testosterone: β = -3.67, 95% CI: -6.66, -0.69) during infancy in male infants.
We observed associations between prenatal sex steroid hormone exposure and birthweight, neonatal adiposity and infant growth that were sex and gestational timing dependent. Our findings suggest further investigation on additional mechanisms linking prenatal sex steroid exposure and fetal/postnatal growth is needed.
宫内因素会影响胎儿及儿童的生长发育,可能是儿童肥胖发育起源的潜在原因。孕期暴露于性甾体激素是一个合理的研究对象,因为它会对胎盘血管形成、营养物质运输、脂肪生成和表观遗传修饰产生影响。在本研究中,我们评估了孕期各阶段母体性甾体激素与出生体重、新生儿肥胖及婴儿生长轨迹之间的关系,并评估了发育的敏感窗口期。
分析纳入了来自一个前瞻性妊娠队列且足月分娩的参与者(n = 252)。使用高效液相色谱和串联质谱法评估整个孕期的雌酮、雌二醇、雌三醇以及总睾酮和游离睾酮。采用路径分析来评估孕期各阶段性甾体激素与出生结局及婴儿生长轨迹(出生至12个月)之间的直接关联,对协变量进行调整并考虑性别差异。
产前性甾体激素与胎儿/婴儿生长之间的关联因性别和激素暴露时间而异。孕早期雌酮与女婴出生时较高的出生体重z评分(β = 0.37,95%CI:0.02,0.73)和躯干皮褶厚度(TST)(β = 0.94,95%CI:0.34,1.54)相关。孕晚期总睾酮与男女两性出生时较高的TST相关(β = 0.47,95%CI:0.03,0.86)。与低稳定体重轨迹相比,孕早期雌酮和雌二醇以及孕早期和孕晚期睾酮与男婴婴儿期高稳定体重轨迹的概率较低相关(雌酮:β = -3.87,95%CI:-6.59,-1.16;雌二醇:β = -4.36,95%CI:-7.62,-1.11;孕早期睾酮:β = -3.53,95%CI:-6.63,-0.43;孕晚期睾酮:β = -3.67,95%CI:-6.66,-0.69)。
我们观察到产前性甾体激素暴露与出生体重、新生儿肥胖及婴儿生长之间的关联存在性别和孕周依赖性。我们的研究结果表明,需要进一步研究将产前性甾体激素暴露与胎儿/出生后生长联系起来的其他机制。